Proteomic biomarkers in combination with CA 125 for detection of epithelial ovarian cancer using prediagnostic serum samples from the Prostate, Lung, Colorectal, and Ovarian (PLCO) Cancer Screening Trial.

Proteomic biomarkers in combination with CA 125 for detection of epithelial ovarian cancer using prediagnostic serum samples from the Prostate, Lung, Colorectal, and Ovarian (PLCO) Cancer Screening Trial. Cancer. 2012 Jan 01; 118(1):91-100.

View in: PubMed

subject areas

Aged
Biomarkers, Tumor
CA-125 Antigen
Case-Control Studies
Early Detection of Cancer
Female
Humans
Middle Aged
Neoplasms, Glandular and Epithelial
Ovarian Neoplasms
Proteomics
Sensitivity and Specificity

authors with profiles

ROBERT C BAST JR
KAREN H LU